Cargando…
Abrin Immunotoxin: Targeted Cytotoxicity and Intracellular Trafficking Pathway
BACKGROUND: Immunotherapy is fast emerging as one of the leading modes of treatment of cancer, in combination with chemotherapy and radiation. Use of immunotoxins, proteins bearing a cell-surface receptor-specific antibody conjugated to a toxin, enhances the efficacy of cancer treatment. The toxin A...
Autores principales: | Gadadhar, Sudarshan, Karande, Anjali A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589266/ https://www.ncbi.nlm.nih.gov/pubmed/23472175 http://dx.doi.org/10.1371/journal.pone.0058304 |
Ejemplares similares
-
Mechanistic Insights into the Neutralization of Cytotoxic Abrin by the Monoclonal Antibody D6F10
por: Bagaria, Shradha, et al.
Publicado: (2013) -
Efficiency of Immunotoxin Cytotoxicity Is Modulated by the Intracellular Itinerary
por: Tortorella, Lori L., et al.
Publicado: (2012) -
The effect of ricin B chain on the intracellular trafficking of an A chain immunotoxin.
por: Timar, J., et al.
Publicado: (1991) -
Endoplasmic Reticulum Stress-Mediated Activation of p38 MAPK, Caspase-2 and Caspase-8 Leads to Abrin-Induced Apoptosis
por: Mishra, Ritu, et al.
Publicado: (2014) -
Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.
por: Wawrzynczak, E. J., et al.
Publicado: (1992)